Introduction
The coronavirus 2019 (COVID-19) has been spreading rapidly from person
to person and causing widespread disease over the world since the end of
2019. The spectrum of COVID-19 virus infection ranges from asymptomatic
cases to fatal pneumonia. At the beginning of the pandemic, it was said
that the most illnesses due to this virus could be self-limited, with an
abrupt onset of fever and respiratory symptoms. With the increase of
cases all over the world due to the high transmission rate, more
symptoms such as fatigue, myalgia, diarrhea, loss of taste and smell
have been described as the typical symptoms of COVID-19, and the high
mortality rate has been shown among cases with co-morbid diseases.
The signs, symptoms, or laboratory findings of the effects of this
illness on the urinary tract system have not yet been fully described in
the literature (5-2). Firstly, Mumm et al found that urinary frequency
might be a symptom of COVID-19 (5), then Luciani et al reported three
cases of gross hematuria (6). While Sun et al firstly isolated the virus
from the urine of a COVID-19 patient (8), Liu et al found that the
positive rates of glucosuria and proteinuria may have a role on the
differentiation of the severity of COVID-19 (1). According to our
knowledge, there have been no reports that COVID-19 patients have been
evaluated with a standardized questionnaire about their urinary tract
system. In this study, we aimed to show if lower urinary tract symptoms
(LUTS) could be symptoms of COVID-19 with validated questionnaires.